These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1790304)

  • 1. Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells.
    Bedrosian I; Sofia RD; Wolff SM; Dinarello CA
    Cytokine; 1991 Nov; 3(6):568-75. PubMed ID: 1790304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine.
    Watson RW; Redmond HP; Mc Carthy J; Bouchier-Hayes D
    J Leukoc Biol; 1995 Sep; 58(3):299-306. PubMed ID: 7665985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurolidine inhibits tumour necrosis factor (TNF) toxicity--new evidence of TNF and endotoxin synergy.
    Monson JR; Ramsey PS; Donohue JH
    Eur J Surg Oncol; 1993 Jun; 19(3):226-31. PubMed ID: 8314379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.
    Sirko SP; Schindler R; Doyle MJ; Weisman SM; Dinarello CA
    Eur J Immunol; 1991 Feb; 21(2):243-50. PubMed ID: 1847874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes.
    Dofferhoff AS; Esselink MT; de Vries-Hospers HG; van Zanten A; Bom VJ; Weits J; Vellenga E
    J Antimicrob Chemother; 1993 Mar; 31(3):373-84. PubMed ID: 8486571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.
    Feist W; Ulmer AJ; Wang MH; Musehold J; Schlüter C; Gerdes J; Herzbeck H; Brade H; Kusumoto S; Diamantstein T
    FEMS Microbiol Immunol; 1992 Jan; 4(2):73-89. PubMed ID: 1547025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-alpha production in rat mesangial cell cultures.
    Leithäuser ML; Rob PM; Sack K
    Exp Nephrol; 1997; 5(1):100-4. PubMed ID: 9052855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
    Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
    Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurolidine inhibits tumor cell growth in vitro and in vivo.
    McCourt M; Wang JH; Sookhai S; Redmond HP
    Ann Surg Oncol; 2000 Oct; 7(9):685-91. PubMed ID: 11034247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.
    Drenth JP; Göertz J; Daha MR; van der Meer JW
    Immunology; 1996 Jul; 88(3):355-62. PubMed ID: 8774350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
    Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
    J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Antiseptic and Antineoplastic Agent Taurolidine Modulates Key Leukocyte Functions.
    Wouters Y; Mennen GRH; Te Morsche RHM; Roelofs HMJ; Wanten GJA
    In Vivo; 2022; 36(5):2074-2082. PubMed ID: 36099103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with autologous platelets multiplies interleukin-1 and tumor necrosis factor production in mononuclear cells.
    Aiura K; Clark BD; Dinarello CA; Margolis NH; Kaplanski G; Burke JF; Tompkins RG; Gelfand JA
    J Infect Dis; 1997 Jan; 175(1):123-9. PubMed ID: 8985205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of theophylline on the production of interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 by human peripheral blood mononuclear cells.
    Yoshimura T; Usami E; Kurita C; Watanabe S; Nakao T; Kobayashi J; Yamazaki F; Nagai H
    Biol Pharm Bull; 1995 Oct; 18(10):1405-8. PubMed ID: 8593446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells.
    Hâncu N; Netea MG; Baciu I
    Rom J Physiol; 1998; 35(3-4):325-30. PubMed ID: 11061332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(5):322-30. PubMed ID: 8370323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
    Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
    Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall.
    Caruso F; Darnowski JW; Opazo C; Goldberg A; Kishore N; Agoston ES; Rossi M
    PLoS One; 2010 Jan; 5(1):e8927. PubMed ID: 20126631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats.
    Rosman C; Westerveld GJ; van Oeveren W; Kooi K; Bleichrodt RP
    Eur Surg Res; 1996; 28(5):351-60. PubMed ID: 8880124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.